Infusion Pumps Propel Global Market Upwards

The global infusion pumps market is expected to grow at a compound annual growth rate (CAGR) of 5.3%, reaching an estimated value of USD 7.8 billion in 2019. These are the latest findings of Transparency Market Research (Albany, NY, USA), a global market intelligence company.

Infusion pumps are used to deliver therapeutic drugs and fluids such as plasma, dextrose, and saline solutions at a precisely controlled rate through several routes of administration, such as intravenous (IV), epidural, arterial, subcutaneous, peritoneal, enteral, and intrathecal. A large segment of the global population suffering from diseases such as cancer, diabetes, and chronic pain has been a major driver for growth of the infusion pumps market, and the increasing burden of these diseases is expected to drive a significant market growth in the near future.

On the basis of type of device, the market is divided into large volume infusion pumps, disposable infusion pumps, syringe infusion pumps, ambulatory infusion pumps, and implantable infusion pumps. In 2012, large volume infusion pumps accounted for the largest share by revenue of the global infusion pumps market, followed by disposable infusion pumps. Large volume infusion pumps form the largest product segment in the market due to several advantages, such as numerous application areas, higher accuracy in infusions, wider infusion time range, dose calculation software, and wireless integration of infusion data for electronic medical records.

North America was the largest market for infusion devices in 2012, and contributed 44% of the global infusion pumps market revenue in the same year. The demand for more advanced infusion systems from other developed nations such as Canada, the United Kingdom, France, Germany, Australia, Japan, and Singapore is likely to serve as a good opportunity for leading players in the market. However, the quantum growth in infusion pumps market is expected to be driven by developing countries, which have a large population base and increasing attention towards healthcare infrastructure.

During the forecast period (2013 to 2019), the Asia-Pacific region, specifically India and China, is expected to grow at a much faster rate than other regions due to the large patient base and increasing incidences of diabetes and cancer. The magnitude of malnutrition in this region is also very high, which is expected to trigger the demand for infusion pumps for clinical nutrition. A significant rise in healthcare expenditure of these developing economies will continue to boost the demand for infusion pumps in this region.

The global infusion pumps market is dominated by a few major players such as CareFusion (San Diego, CA, USA), Hospira, Baxter International, Fresenius Kabi (Bad Homburg, Germany), B. Braun Melsungen, and Terumo (Tokyo, Japan).

Related Links:
Transparency Market Research
CareFusion
Fresenius Kabi